Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Sarcoma, Ewing × Methoxsalen × Sarcoma × Clear all

Phase

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Sezary Syndrome 1 Sarcoma, Ewing 1 Sarcoma 1 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Neoplasms, Plasma Cell 1 Myelodysplastic Syndromes 1 Mycosis Fungoides 1 Multiple Myeloma 1 Lymphoma, T-Cell, Cutaneous 1 Lymphoma, Non-Hodgkin 1 Lymphoma, Mantle-Cell 1 Lymphoma, Large-Cell, Immunoblastic 1 Lymphoma, Large-Cell, Anaplastic 1 Lymphoma, Large B-Cell, Diffuse 1 Lymphoma, Follicular 1 Lymphoma 1 Leukemia, Promyelocytic, Acute 1 Leukemia, Prolymphocytic 1 Leukemia, Myelomonocytic, Chronic 1 Leukemia, Myelomonocytic, Acute 1 Leukemia, Myeloid, Chronic-Phase 1 Leukemia, Myeloid, Acute 1 Leukemia, Myeloid, Accelerated Phase 1 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 1 Leukemia, Monocytic, Acute 1 Leukemia, Megakaryoblastic, Acute 1 Leukemia, Lymphocytic, Chronic, B-Cell 1 Leukemia, Large Granular Lymphocytic 1 Leukemia, Erythroblastic, Acute 1

Interventions

Cyclophosphamide 24 Temozolomide 21 Irinotecan 18 Vincristine 17 Doxorubicin 13 Topotecan 10 Melphalan 10 Etoposide 10 Ifosfamide 8 Busulfan 8 Magnetic Resonance Spectroscopy 7 Granulocyte Colony-Stimulating Factor 7 Filgrastim 6 cabozantinib 5 X-Rays 5 Specimen Handling 5 Sirolimus 5 Drug Therapy 5 regorafenib 4 pegfilgrastim 4 palbociclib 4 liposomal doxorubicin 4 fludarabine phosphate 4 fludarabine 4 Trabectedin 4 Radiotherapy 4 Phantoms, Imaging 4 Nivolumab 4 Gemcitabine 4 FANG vaccine 4

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03778996 2025-02-24

HopES

Sarcoma Oncology Research Center, LLC

Phase 2 Active not recruiting

Sarcoma, Sarcoma, Ewing

Data powered by HemOnc (CC BY 4.0) Colophon ⚡